AARP Endorses Plan by Senators Van Hollen and Scott to Lower Prescription Drug Costs
August 15, 2019
August 15, 2019
WASHINGTON, Aug. 15 -- Sen. Chris Van Hollen, D-Maryland, issued the following news release:
Today, Senators Chris Van Hollen (D-Md.) and Rick Scott (R-Fl.) applauded AARP's endorsement of their We Protect American Investment in Drugs (PAID) Act of 2019 to address the soaring cost of prescription drug prices. The We PAID Act prohibits pharmaceutical companies from charging American consumers unreasonable prices for life-saving drugs when the companies develop prescription drugs usin . . .
Today, Senators Chris Van Hollen (D-Md.) and Rick Scott (R-Fl.) applauded AARP's endorsement of their We Protect American Investment in Drugs (PAID) Act of 2019 to address the soaring cost of prescription drug prices. The We PAID Act prohibits pharmaceutical companies from charging American consumers unreasonable prices for life-saving drugs when the companies develop prescription drugs usin . . .